INTEGRATED BIOPHARMA INC (INBP) Return on equity 2019–2025
INTEGRATED BIOPHARMA INC (INBP) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
4.0%FY2025 · since FY2019: 89.2% → 4.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 4.0% | +3.4 pp |
| FY2024 | 0.6% | +0.8 pp |
| FY2023 | -0.2% | -20.8 pp |
| FY2022 | 20.7% | -35.2 pp |
| FY2021 | 55.9% | -11.8 pp |
| FY2020 | 67.7% | -21.5 pp |
| FY2019 | 89.2% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice